Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease

Circulation

Volumn 102, Issue 10, 2000, Pages 1101-1106

  Roe, Matthew T ^a   Harrington, Robert A ^a   Prosper, Danielle M ^b   Pieper, Karen S ^a   Bhatt, Deepak L ^b   Lincoff, A Michael ^b   Simoons, Maarten L ^c   Akkerhuis, Martijn ^c   Ohman, E Magnus ^a   Kitt, Michael M ^d   Vahanian, Alec ^e   Ruzyllo, Witold ^f   Karsch, Karl ^g   Califf, Robert M ^a   Topol, Eric J ^b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d MILLENNIUM PHARMACEUTICALS INC   (United States)

^e HÔPITAL TENON   (France)

^f INSTITUTE OF CARDIOLOGY   (Poland)

^g UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Angiography; Coronary disease; Ischemia; Platelets; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EPTIFIBATIDE; HEPARIN; PLACEBO;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 20244367280     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.10.1101     Document Type: Article

References (25)

1. The pathogenesis of coronary artery disease and the acute coronary syndromes
2. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes
3. Intracoronary thrombus and complex morphology in unstable angina
4. Angiographic morphology in unstable angina
5. Angiographic morphology in unstable angina and its relation to transient myocardial ischemia and hospital outcome
6. Correlation of angiographic morphology and clinical presentation in unstable angina
7. Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable angina
8. Clinical predictors of unstable coronary lesion morphology
9. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA trial)
10. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
11. Design and methodology of the PURSUIT trial: Evaluating eptifibatide for acute ischemic coronary syndromes
12. Thrombolysis in Myocardial Infarction (TIMI) trial-phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
13. Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome
14. Design: S plus functions for biostatistical/epidemiologic modeling, testing, estimation, validation, graphics, prediction, and type-setting by storing enhanced model design attributes for the fit
15. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes
16. Angiographic stenosis progression and coronary events in patients with 'stabilized' unstable angina
17. Angiographic evolution of coronary artery morphology in unstable angina
18. Presentation and late outcome of myocardial infarction in the absence of angiographically significant coronary artery disease
19. Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain
20. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms
21. Angiographic findings in patients with refractory unstable angina according to troponin T status
22. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q-wave myocardial infarction: Results of the TIMI III Registry Ancillary Study
23. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels
24. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban
25. Answers to complex questions cannot be derived from 'simple' trials